These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
419 related items for PubMed ID: 12710010
21. Parkinsonian motor deficits are reflected by proportional A9/A10 dopamine neuron degeneration in the rat. Moore AE, Cicchetti F, Hennen J, Isacson O. Exp Neurol; 2001 Dec; 172(2):363-76. PubMed ID: 11716560 [Abstract] [Full Text] [Related]
22. Neuroprotective and neurotrophic effect of apomorphine in the striatal 6-OHDA-lesion rat model of Parkinson's disease. Yuan H, Sarre S, Ebinger G, Michotte Y. Brain Res; 2004 Nov 05; 1026(1):95-107. PubMed ID: 15476701 [Abstract] [Full Text] [Related]
23. Relation between rotation in the 6-OHDA lesioned rat and dopamine loss in striatal and substantia nigra subregions. Olds ME, Jacques DB, Kopyov O. Synapse; 2006 Jun 15; 59(8):532-44. PubMed ID: 16565974 [Abstract] [Full Text] [Related]
24. Influence of time in culture and BDNF pretreatment on survival and function of grafted embryonic rat ventral mesencephalon in the 6-OHDA rat model of Parkinson's disease. Höglinger GU, Widmer HR, Spenger C, Meyer M, Seiler RW, Oertel WH, Sautter J. Exp Neurol; 2001 Jan 15; 167(1):148-57. PubMed ID: 11161602 [Abstract] [Full Text] [Related]
25. Amphetamine-induced abnormal movements occur independently of both transplant- and host-derived serotonin innervation following neural grafting in a rat model of Parkinson's disease. Lane EL, Brundin P, Cenci MA. Neurobiol Dis; 2009 Jul 15; 35(1):42-51. PubMed ID: 19361557 [Abstract] [Full Text] [Related]
26. A 6-hydroxydopamine-induced selective parkinsonian rat model: further biochemical and behavioral characterization. Thomas J, Wang J, Takubo H, Sheng J, de Jesus S, Bankiewicz KS. Exp Neurol; 1994 Apr 15; 126(2):159-67. PubMed ID: 7925817 [Abstract] [Full Text] [Related]
27. Effects of intranigral vs intrastriatal fetal mesencephalic neural grafts on motor behavior disorders in a rat Parkinson model. Goren B, Kahveci N, Eyigor O, Alkan T, Korfali E, Ozluk K. Surg Neurol; 2005 Apr 15; 64 Suppl 2():S33-41. PubMed ID: 16256839 [Abstract] [Full Text] [Related]
28. Fetal striatal transplants restore electrophysiological sensitivity to dopamine in the lesioned striatum of rats with experimental Huntington's disease. Chen GJ, Jeng CH, Lin SZ, Tsai SH, Wang Y, Chiang YH. J Biomed Sci; 2002 Apr 15; 9(4):303-10. PubMed ID: 12145527 [Abstract] [Full Text] [Related]
29. Impaired acquisition of skilled behavior in rotarod task by moderate depletion of striatal dopamine in a pre-symptomatic stage model of Parkinson's disease. Ogura T, Ogata M, Akita H, Jitsuki S, Akiba L, Noda K, Hoka S, Saji M. Neurosci Res; 2005 Mar 15; 51(3):299-308. PubMed ID: 15710494 [Abstract] [Full Text] [Related]
30. Hemiparkinsonian rats rotate toward the side with the weaker dopaminergic neurotransmission. Da Cunha C, Wietzikoski EC, Ferro MM, Martinez GR, Vital MA, Hipólide D, Tufik S, Canteras NS. Behav Brain Res; 2008 Jun 03; 189(2):364-72. PubMed ID: 18328580 [Abstract] [Full Text] [Related]
31. [Simultaneous transplantation of fetal mesencephalic cells to the striatum and globus pallidus of rats with lesions induced by 6-hydroxydopamine]. Alvarez-Fonseca P, Blanco L, Pavón N, Vidal L, Castellano O, Castillo L, García A, Rosillo JC, Macías R. Rev Neurol; 1998 Apr 03; 26(152):537-40. PubMed ID: 9795999 [Abstract] [Full Text] [Related]
32. Lesioning of the striatum reverses motor asymmetry in the 6-hydroxydopamine rodent model of parkinsonism. Friehs GM, Parker RG, He LS, Haines SJ, Turner DA, Ebner TJ. J Neural Transplant Plast; 1991 Apr 03; 2(2):141-56. PubMed ID: 1684115 [Abstract] [Full Text] [Related]
33. Dopaminergic transplants normalize amphetamine- and apomorphine-induced Fos expression in the 6-hydroxydopamine-lesioned striatum. Cenci MA, Kalén P, Mandel RJ, Wictorin K, Björklund A. Neuroscience; 1992 Apr 03; 46(4):943-57. PubMed ID: 1347413 [Abstract] [Full Text] [Related]
34. Ginkgo biloba affords dose-dependent protection against 6-hydroxydopamine-induced parkinsonism in rats: neurobehavioural, neurochemical and immunohistochemical evidences. Ahmad M, Saleem S, Ahmad AS, Yousuf S, Ansari MA, Khan MB, Ishrat T, Chaturvedi RK, Agrawal AK, Islam F. J Neurochem; 2005 Apr 03; 93(1):94-104. PubMed ID: 15773909 [Abstract] [Full Text] [Related]
35. Neurorescue effects of VEGF on a rat model of Parkinson's disease. Yasuhara T, Shingo T, Muraoka K, Kameda M, Agari T, Wen Ji Y, Hayase H, Hamada H, Borlongan CV, Date I. Brain Res; 2005 Aug 16; 1053(1-2):10-8. PubMed ID: 16045899 [Abstract] [Full Text] [Related]
36. [Transplantation of fetal dopaminergic cells simultaneously to the corpus striatum and pars reticularis of the substantia nigra in hemi-parkinsonian rats]. Blanco L, Pavón N, Alvaŕez P, Díaz C, Castellano O, Castillo L, de la Cuétara K, Macías R. Rev Neurol; 1998 Mar 16; 26(151):361-5. PubMed ID: 9585942 [Abstract] [Full Text] [Related]
37. Characterization of behavioral and neurodegenerative changes following partial lesions of the nigrostriatal dopamine system induced by intrastriatal 6-hydroxydopamine in the rat. Kirik D, Rosenblad C, Björklund A. Exp Neurol; 1998 Aug 16; 152(2):259-77. PubMed ID: 9710526 [Abstract] [Full Text] [Related]
38. Nerve growth factor increases survival of dopaminergic graft, rescue nigral dopaminergic neurons and restores functional deficits in rat model of Parkinson's disease. Chaturvedi RK, Shukla S, Seth K, Agrawal AK. Neurosci Lett; 2006 May 01; 398(1-2):44-9. PubMed ID: 16423459 [Abstract] [Full Text] [Related]
39. Delayed gene therapy of glial cell line-derived neurotrophic factor is efficacious in a rat model of Parkinson's disease. Zheng JS, Tang LL, Zheng SS, Zhan RY, Zhou YQ, Goudreau J, Kaufman D, Chen AF. Brain Res Mol Brain Res; 2005 Mar 24; 134(1):155-61. PubMed ID: 15790539 [Abstract] [Full Text] [Related]
40. Olfactory ensheathing cell transplantation restores functional deficits in rat model of Parkinson's disease: a cotransplantation approach with fetal ventral mesencephalic cells. Agrawal AK, Shukla S, Chaturvedi RK, Seth K, Srivastava N, Ahmad A, Seth PK. Neurobiol Dis; 2004 Aug 24; 16(3):516-26. PubMed ID: 15262263 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]